Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars
Burn survivors frequently face a distressing secondary complication known as hypertrophic scarring, where the skin heals in bumpy, uneven, and raised...
Search results for "second quarter"
Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?
“It doesn’t end with lazertinib. Keep an eye out for the next candidate in line.” Oscotec is aggressively channeling the revenue secured from the...
Rejuran Cosmetics Sales Surge 51%: PharmaResearch Finds New Growth Engine
PharmaResearch is successfully diversifying its business model, transitioning from a medical device-centric structure...
Why Rokit Healthcare’s Stock Soared Despite Geopolitical Volatility
Rokit Healthcare is capturing significant market attention for its robust momentum. Its stock price has surged 50% over...
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?
Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
From 8.7 Billion Deficit to 16.3 Billion Surplus: Seers Strikes Gold in the Middle East
"We have been working to penetrate the Middle Eastern market since 2018. The pricing per bed and equipment costs there...
Kazakhstan, Indonesia, Mongolia… Emerging as Major Spenders in Korea’s Medical Tourism
The number of foreign patients who visited Korea surpassed 1 million for the first time last year.
“Kazakhstan, Indonesia, Mongolia… Emerging as Big Spenders in Korea’s Medical Tourism”
The number of foreign patients who visited Korea surpassed 1 million for the first time last year.